Growth Metrics

Cresco Labs (CRLBF) Accounts Payables (2019 - 2026)

Cresco Labs filings provide 8 years of Accounts Payables readings, the most recent being $14.2 million for Q1 2026.

  • On a quarterly basis, Accounts Payables changed N/A to $14.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $14.2 million, a N/A change, with the full-year FY2025 number at $16.5 million, changed N/A from a year prior.
  • Accounts Payables hit $14.2 million in Q1 2026 for Cresco Labs, down from $16.5 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $37.0 million in Q2 2022 to a low of $7.1 million in Q1 2022.
  • Median Accounts Payables over the past 5 years was $18.1 million (2024), compared with a mean of $20.4 million.
  • Biggest five-year swings in Accounts Payables: skyrocketed 173.2% in 2022 and later tumbled 40.45% in 2024.
  • Cresco Labs' Accounts Payables stood at $14.7 million in 2022, then skyrocketed by 87.9% to $27.6 million in 2023, then plummeted by 30.57% to $19.2 million in 2024, then dropped by 13.65% to $16.5 million in 2025, then decreased by 14.31% to $14.2 million in 2026.
  • The last three reported values for Accounts Payables were $14.2 million (Q1 2026), $16.5 million (Q4 2025), and $19.2 million (Q3 2024) per Business Quant data.